Menu Search
Equities

Agilent Technologies Inc

A:NYQ

Agilent Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)133.84
  • Today's Change1.78 / 1.35%
  • Shares traded2.07m
  • 1 Year change+7.94%
  • Beta1.0615
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

SmartText is unavailable
Gross margin54.75%
Net profit margin21.75%
Operating margin23.56%
Return on assets13.04%
Return on equity24.66%
Return on investment16.13%
More ▼

Cash flow in USDView more

In 2023, Agilent Technologies Inc increased its cash reserves by 50.85%, or 537.00m. The company earned 1.77bn from its operations for a Cash Flow Margin of 25.93%. In addition the company used 310.00m on investing activities and also paid 930.00m in financing cash flows.
Cash flow per share5.67
Price/Cash flow per share22.82
Book value per share20.53
Tangible book value per share5.38
More ▼

Balance sheet in USDView more

Agilent Technologies Inc has a Debt to Total Capital ratio of 33.19%, a lower figure than the previous year's 49.19%.
Current ratio1.78
Quick ratio1.37
Total debt/total equity0.4967
Total debt/total capital0.3319
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 7.40% while earnings per share excluding extraordinary items growth only marginally increased 0.22%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.66%
Div growth rate (5 year)8.86%
Payout ratio (TTM)19.25%
EPS growth(5 years)9.42
EPS (TTM) vs
TTM 1 year ago		25.97
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.